Novo Nordisk on FORTUNE's "100 Best Companies to Work For" list for second consecutive year

Novo Nordisk, a global healthcare company focusing on diabetes care, has been named to FORTUNE Magazine's list of "100 Best Companies to Work For" 2010.  This is the second consecutive year that Novo Nordisk has been recognized with this prestigious award. Novo Nordisk moved up to 25 from 57 in the overall list and is only one of two pharmaceutical/biotechnology companies so honored.    

"This continued recognition by FORTUNE as one of the '100 Best Companies to Work For' is a reflection of the passion of our employees," said Jerzy Gruhn, president of Novo Nordisk Inc. "Our ambition to defeat diabetes is one that is shared equally throughout Novo Nordisk, from the field to the home office to the lab bench."

To pick the 100 Best Companies, FORTUNE partners with the Great Place to Work Institute® to conduct the most extensive employee survey in corporate America. Most (two-thirds) of a company's score is based on the results of the Institute's Trust Index survey, which is sent to a random sample of employees from each company. This year, 343 companies participated in the survey. FORTUNE's "100 Best Companies to Work For" are historically good performers in the marketplace for not only current and prospective employees, but shareholders as well.

"At Novo Nordisk, we believe strongly in cultivating the talent of our employees and rewarding them for contributing to the success of our business," said Jeff Frazier, Vice President of Human Resources.  "This has enabled us to attract and retain the most-talented people with a passion for advancing the treatment and care of the patients who use our products."

SOURCE Novo Nordisk


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment